Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

IL-17-producing γδ T cells help improve bone healing.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Atopy and altered T cell functions contribute to Alopecia Areata.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Recent dermatological research highlights include new virus discoveries, genetic links to skin conditions, and insights into skin healing and pigmentation.